Mallinckrodt Plc (NYSE:MNK)

16.44
Delayed Data
As of 4:02pm ET
 +0.11 / +0.67%
Today’s Change
11.65
Today|||52-Week Range
49.12
-27.13%
Year-to-Date

Today’s Trading

Previous close16.33
Today’s open16.23
Day’s range16.13 - 16.59
Volume1,496,125
Average volume (3 months)3,803,760
Market cap$1.3B
Data as of 4:02pm ET, 05/24/2018

Growth & Valuation

Earnings growth (last year)+268.38%
Earnings growth (this year)-16.70%
Earnings growth (next 5 years)-1.00%
Revenue growth (last year)-4.71%
P/E ratio0.9
Price/Sales0.69
Price/Book0.21

Competitors

----
AKRXAkorn Inc+0.30+2.19%
PBYIPuma Biotechnology I...+0.65+1.28%
OPKOPKO Health Inc+0.05+1.37%
Data as of 4:00pm ET, 05/24/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)$1.54
Annual revenue (last year)$3.2B
Annual profit (last year)$1.8B
Net profit margin54.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
EVP-Global Operations &
Digital Innovation Officer
Frank Scholz
Corporate headquarters
Staines-Upon-Thames, Surrey

Forecasts